<?xml version="1.0" encoding="UTF-8"?>
<p id="p0350">As for the tannin extracts, another ongoing trial using the compound aescin (
 <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04322344?term=Aescin&amp;cond=Viral+Infection&amp;draw=2&amp;rank=1" id="intref0070" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04322344</ext-link>) aims to evaluate its efficacy and safety as an adjuvant to conventional antiviral drugs in COVID-19 patients.
</p>
